Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A

Patients with the severe form of hemophilia A (HA) present with a severe phenotype, and can suffer from life-threatening, spontaneous hemorrhaging. While prophylactic FVIII infusions have revolutionized the clinical management of HA, this treatment is short-lived, expensive, and it is not available...

Descripción completa

Detalles Bibliográficos
Autores principales: Stem, Christopher, Rodman, Christopher, Ramamurthy, Ritu M., George, Sunil, Meares, Diane, Farland, Andrew, Atala, Anthony, Doering, Christopher B., Spencer, H. Trent, Porada, Christopher D., Almeida-Porada, Graça
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383113/
https://www.ncbi.nlm.nih.gov/pubmed/34447745
http://dx.doi.org/10.3389/fcell.2021.678117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383113/
https://www.ncbi.nlm.nih.gov/pubmed/34447745
http://dx.doi.org/10.3389/fcell.2021.678117

Ejemplares similares